Abstract
A wealth of evidence supports the use of beta-blockers in stable angina pectoris and myocardial infarction, both early and late. The situation in unstable angina is less well illuminated, but forthcoming results of trials will hopefully close some of this gap.
MeSH terms
-
Adrenergic beta-Antagonists / adverse effects
-
Adrenergic beta-Antagonists / therapeutic use*
-
Angina Pectoris / drug therapy
-
Angina, Unstable / drug therapy
-
Coronary Circulation / drug effects
-
Coronary Disease / drug therapy*
-
Drug Tolerance
-
Hemodynamics / drug effects
-
Humans
-
Myocardial Infarction / drug therapy
-
Prognosis
Substances
-
Adrenergic beta-Antagonists